Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Junia Pharma
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Junia Pharma
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
it
en
19 April 2024
Rendiconto sintetico delle votazioni
19 April 2024
Verbale approvazione fusione
15 April 2024
THE MERGER BY INCORPORATION INTO PHARMANUTRA S.P.A. OF JUNIA PHARMA S.R.L. AND ALESCO S.R.L. HAS BEEN APPROVED
26 March 2024
Explanatory Memorandum on Authorisation to purchase and use trasury shares
26 March 2024
Explanatory Memorandum on Authorisation to purchase and use trasury shares
25 March 2024
ANNUAL FINANCIAL REPORT 31/12/2023
25 March 2024
REPORT ON CORPORATE GOVERNANCE AND OWNERSHIP STRUCTURE OF PHARMANUTRA S.P.A.
18 March 2024
STAR CONFERENCE 2024
15 March 2024
NOTICE CALLING THE ORDINARY GENERAL MEETING OF SHAREHOLDERS
15 March 2024
2023 FY FINANCIAL RESULTS ANALYST
15 March 2024
Explanatory memorandum on the increase in compensation for the Board of Statutory Auditors
15 March 2024
Explanatory memorandum to amend total fixed annual remuneration of the BoD
1
2
…
16
>